The "Frankenstein Instrument" Problem Why Some PRO Measures Don't Fit Today's Patients
Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lea...
14 Syys 23min
Why eConsent Still Isn’t Standard in Clinical Trials—and What Could Change That
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinic...
4 Elo 19min
Nothing Remains the Same: Why Measures Have to Evolve
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk abo...
21 Heinä 23min
The Missing Link: Why Study Design Makes or Breaks a Clinical Trial
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study d...
9 Kesä 22min
Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, t...
5 Touko 27min
More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner at Sprout Health Solutions, to discuss how...
23 Maalis 23min
Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a beh...
10 Helmi 20min
Meaningful patient involvement in HTA decision making: where do we go from here?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer UK, to discuss how vari...
7 Loka 202519min
